Genomic Profiling of Circulating Tumor DNA From Cerebrospinal Fluid to Guide Clinical Decision Making for Patients With Primary and Metastatic Brain Tumors

Despite advances in systemic therapies for solid tumors, the development of brain metastases remains a significant contributor to overall cancer mortality and requires improved methods for diagnosing and treating these lesions. Similarly, the prognosis for malignant primary brain tumors remains poor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Neurol
Autors principals: Ramkissoon, Lori A., Pegram, Worthy, Haberberger, James, Danziger, Natalie, Lesser, Glenn, Strowd, Roy, Dahiya, Sonika, Cummings, Thomas J., Bi, Wenya Linda, Abedalthagafi, Malak, Sathyan, Pratheesh, McGregor, Kimberly, Reddy, Prasanth, Severson, Eric, Williams, Erik, Lin, Douglas, Edgerly, Claire, Huang, Richard S. P., Hemmerich, Amanda, Creeden, James, Brown, Charlotte, Venstrom, Jeffrey, Hegde, Priti, Ross, Jeffrey S., Alexander, Brian M., Elvin, Julia, Ramkissoon, Shakti H.
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Neurology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7604477/
https://ncbi.nlm.nih.gov/pubmed/33192972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.544680
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars